13-30921699-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_032849.4(MEDAG):c.640G>A(p.Val214Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000564 in 1,614,040 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_032849.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MEDAG | NM_032849.4 | c.640G>A | p.Val214Ile | missense_variant | 4/5 | ENST00000380482.9 | NP_116238.3 | |
TEX26-AS1 | NR_038287.1 | n.1437+9102C>T | intron_variant, non_coding_transcript_variant | |||||
MEDAG | XM_017020801.2 | c.187G>A | p.Val63Ile | missense_variant | 3/4 | XP_016876290.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MEDAG | ENST00000380482.9 | c.640G>A | p.Val214Ile | missense_variant | 4/5 | 1 | NM_032849.4 | ENSP00000369849 | P1 | |
TEX26-AS1 | ENST00000585870.6 | n.1437+9102C>T | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152206Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000717 AC: 18AN: 251164Hom.: 0 AF XY: 0.0000884 AC XY: 12AN XY: 135762
GnomAD4 exome AF: 0.0000499 AC: 73AN: 1461716Hom.: 0 Cov.: 31 AF XY: 0.0000468 AC XY: 34AN XY: 727152
GnomAD4 genome AF: 0.000118 AC: 18AN: 152324Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74486
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 05, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at